Mon.Jun 10, 2024

article thumbnail

Knock, Knock – FDA Issues Guidance on Best Processes and Practices During BIMO Inspections

FDA Law Blog

By Sarah Wicks & Anne K. Walsh — Among FDA-regulated establishments and stakeholders, there is one word that makes everyone go on edge – the dreaded FDA “inspection.” In an effort to clarify for industry and alleviate some of the stress associated with these activities, last week the FDA issued a draft guidance aimed at providing recommendations on how to handle inspections under FDA’s Bioresearch Monitoring (BIMO) program.

Provider 111
article thumbnail

Medical Music Mondays: Turn the Heart Rate Down

PEMBlog

Supraventricular tachycardia is really fun to convert. You go do all kinds of vagal maneuvers which are basically heart games. Then there’s the REVERT maneuver – it works great! Search for it and learn it. Or watch this video. Lyrics S V T! A heart rate so fast as fast as can be S V T! EKG super fast rate with no p waves Q R S is narrow, that’s what you will see S V T!

Medical 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

HP&M’s Larry Houck A Panelist in FDLI’s Marijuana Rescheduling Webinar

FDA Law Blog

Last month the Department of Justice and the Drug Enforcement Administration submitted a notice of proposed rulemaking to reschedule cannabis from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. Hyman, Phelps & McNamara, P.C. Director Larry Houck will participate as a panelist focusing on this timely topic in the Food and Drug Law Institute’s (“FDLI’s”) “High Time for a Change: Implications of DEA’s Proposed Marijuana Rescheduling” webinar June 12, 2024, 2:00

59
article thumbnail

More Diversion Cases and WCF’s Opioid & Fentanyl Abuse Management Summit

FDA Law Blog

By Larry K. Houck — It seems as though we cannot get through a week without hearing about controlled substance diversion by employees at another hospital or healthcare facility. We learned this week that Palomar Health, one of California’s largest healthcare districts, agreed to pay $250,000 to resolve allegations that numerous vials of fentanyl had been diverted from automated medication dispensing machines over a five-month period and that the hospital did not properly dispose of unused fentan